David M J Naimark1,2, Nader N Kabboul2, Murray D Krahn1,3. 1. Department of Medicine, University of Toronto, Toronto, ON, Canada (DMJN, MDK). 2. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada (DMJN, NNK) 3. Faculty of Pharmacy, University of Toronto,Toronto, ON, Canada (MDK)
Authors: Björn Stollenwerk; Sergio Iannazzo; Ron Akehurst; Michael Adena; Andrew Briggs; Bastian Dehmel; Patrick Parfrey; Vasily Belozeroff Journal: Pharmacoeconomics Date: 2018-05 Impact factor: 4.981